Acute Icteric Hepatitis Induced By a Short Course of Low-Dose Cyclophosphamide in a Patient with Lupus Nephritis

被引：0
|
作者：
Luigi Muratori
Rodolfo Ferrari
Paolo Muratori
Alessandro Granito
Francesco B. Bianchi
机构：
[1] University of Bologna Policlinico Sant'Orsola-Malpighi via Massarenti,Department of Internal Medicine Cardioangiology Hepatology Alma Mater Studiorum
来源：
Digestive Diseases and Sciences | 2005年 / 50卷
关键词：
Public Health; Hepatitis; Cyclophosphamide; Nephritis; Lupus Nephritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2364 / 2365
页数：1
相关论文
共 50 条
  • [31] Low-Dose Cyclophosphamide Associated with Hemorrhagic Cystitis in a Breast Cancer Patient
    Marshall, Ariela
    McGrath, Cindy
    Torigian, Drew
    Papanicolaou, Nicholas
    Lal, Priti
    Tweed, Carol Kaplan
    BREAST JOURNAL, 2012, 18 (03) : 272 - 275
  • [32] Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study
    Sigdel, Mahesh R.
    Kafle, Mukunda P.
    Shah, Dibya Singh
    BMC NEPHROLOGY, 2016, 17 : 1 - 7
  • [33] Modulatory Effect of the Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen on Circulating Immune Cells in Systemic Lupus Erythematosus
    Gabriela Gabcova
    Pavel Horak
    Zuzana Mikulkova
    Martina Skacelova
    Sarka Zehnalova
    Andrea Smrzova
    Anna Petrackova
    Frantisek Mrazek
    Eva Kriegova
    Archivum Immunologiae et Therapiae Experimentalis, 2019, 67 : 415 - 425
  • [34] Modulatory Effect of the Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen on Circulating Immune Cells in Systemic Lupus Erythematosus
    Gabcova, Gabriela
    Horak, Pavel
    Mikulkova, Zuzana
    Skacelova, Martina
    Zehnalova, Sarka
    Smrzova, Andrea
    Petrackova, Anna
    Mrazek, Frantisek
    Kriegova, Eva
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2019, 67 (06) : 415 - 425
  • [35] The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus
    Weng, Meng-Yu
    Weng, Chia-Tse
    Liu, Ming-Fei
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 771 - 775
  • [36] Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study
    Mahesh R. Sigdel
    Mukunda P. Kafle
    Dibya Singh Shah
    BMC Nephrology, 17
  • [37] Short-interval lower-dose intravenous cyclophosphamide as induction and maintenance therapy for lupus nephritis: a prospective observational study
    X. W. Zhang
    Chun Li
    X. X. Ma
    J. X. Zhao
    Yuan An
    Shuang Liu
    Yan Li
    Z. G. Li
    Clinical Rheumatology, 2014, 33 : 939 - 945
  • [38] Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
    Sedhain, Arun
    Hada, Rajani
    Agrawal, Rajendra K.
    Bhattarai, Gandhi R.
    Baral, Anil
    BMC NEPHROLOGY, 2018, 19
  • [39] Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis
    Arends, S.
    Berden, J. H. M.
    Grootscholten, C.
    Derksen, R. H. W. M.
    Berger, S. P.
    de Sevaux, R. G. L.
    Voskuyl, A. E.
    Bijl, M.
    NETHERLANDS JOURNAL OF MEDICINE, 2014, 72 (09) : 481 - 490
  • [40] Short-interval lower-dose intravenous cyclophosphamide as induction and maintenance therapy for lupus nephritis: a prospective observational study
    Zhang, X. W.
    Li, Chun
    Ma, X. X.
    Zhao, J. X.
    An, Yuan
    Liu, Shuang
    Li, Yan
    Li, Z. G.
    CLINICAL RHEUMATOLOGY, 2014, 33 (07) : 939 - 945
12345